Pharmacy Articles

Pharmacy

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Marr KA - Clinicians should consider using new mold-active azole drugs for prophylaxis instead of fluconazole in allogeneic hematopoietic stem cell transplant recipients that have high risks due to prolonged neutropenia and severe graft vs. host disease. More investigations are needed to support other preventive strategies that utilize diagnostic tests and aerosolized delivery of amphotericin B formulations.

Related Articles

Primary Antifungal Prophylaxis in Adult Hematopoietic Stem Cell Transplant Recipients: Current Therapeutic Concepts
Pharmacotherapy, 10/29/09    Relevance Score: 81%

Colchicine for the Primary and Secondary Prevention of Pericarditis: An Update
Annals of Pharmacotherapy, 11/11/09    Relevance Score: 66%

The Economic Value of Primary Prophylaxis Using Pegfilgrastim Compared with Filgrastim in Patients with Breast Cancer in the UK
Applied Health Economics and Health Policy, 10/20/09    Relevance Score: 65%

Guidelines for prophylaxis and treatment of chemotherapy-induced nausea and vomiting
Bulletin du Cancer, 10/19/09    Relevance Score: 65%

Prophylactic use of antibiotic-loaded bone cement in primary total knee replacement
Knee Surgery, Sports Traumatology, Arthroscopy, 10/05/09    Relevance Score: 65%